Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Stefania De Propris

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Cancers|June 26, 2026
Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free RemissionMaria Stefania De Propris, Alessandro Laganà, Massimo Breccia, et al.
Acta Haematologica|January 21, 2006
High-dose idarubicin, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma responsive to DAV chemotherapy: comparison with a historical controlSaveria Capria, Maria Teresa Petrucci, Alessandro Pulsoni, et al.
Acta Haematologica|March 8, 2003
Possibility of progenitor cell mobilization during the hematological recovery following peripheral blood stem cell autograftMaria Stefania De Propris, Giovanna Meloni, Iole Cordone, et al.
Acta Haematologica|December 21, 2013
Rituximab in previously treated primary immune thrombocytopenia patients: evaluation of short- and long-term efficacy and safetyCristina Santoro, Francesca Biondo, Erminia Baldacci, et al.
Haematologica|July 28, 2011
High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutationMaria Stefania De Propris, Sara Raponi, Daniela Diverio, et al.
Haematologica|July 18, 2009
An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemiaSara Raponi, Maria Stefania De Propris, Hobert Wai, et al.
Leukemia Research|December 4, 2013
Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patientsMassimo Breccia, Maria Stefania De Propris, Clara Minotti, et al.
Hematological Oncology|November 28, 2025
Managing Treatment-Emergent Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CAR-T Cell Therapy: A Case-Based Review of the use of EmapalumabLivia Donzelli, Veronica Zullino, Giovanni Fernando Torelli, et al.
Blood Cells, Molecules & Diseases|December 2, 2022
Neoplastic bone marrow invasion:rapid exclusion of hematological disease by flow cytometric routine panelsMaria Laura Bisegna, Iole Cordone, Nadia Peragine, et al.
British Journal of Haematology|August 16, 2005
The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experienceMassimo Gentile, Francesca Romana Mauro, Elisabetta Calabrese, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Cancers|June 26, 2026
Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free RemissionMaria Stefania De Propris, Alessandro Laganà, Massimo Breccia, et al.
Acta Haematologica|January 21, 2006
High-dose idarubicin, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma responsive to DAV chemotherapy: comparison with a historical controlSaveria Capria, Maria Teresa Petrucci, Alessandro Pulsoni, et al.
Acta Haematologica|March 8, 2003
Possibility of progenitor cell mobilization during the hematological recovery following peripheral blood stem cell autograftMaria Stefania De Propris, Giovanna Meloni, Iole Cordone, et al.
Acta Haematologica|December 21, 2013
Rituximab in previously treated primary immune thrombocytopenia patients: evaluation of short- and long-term efficacy and safetyCristina Santoro, Francesca Biondo, Erminia Baldacci, et al.
Haematologica|July 28, 2011
High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutationMaria Stefania De Propris, Sara Raponi, Daniela Diverio, et al.
Haematologica|July 18, 2009
An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemiaSara Raponi, Maria Stefania De Propris, Hobert Wai, et al.
Leukemia Research|December 4, 2013
Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patientsMassimo Breccia, Maria Stefania De Propris, Clara Minotti, et al.
Hematological Oncology|November 28, 2025
Managing Treatment-Emergent Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CAR-T Cell Therapy: A Case-Based Review of the use of EmapalumabLivia Donzelli, Veronica Zullino, Giovanni Fernando Torelli, et al.
Blood Cells, Molecules & Diseases|December 2, 2022
Neoplastic bone marrow invasion:rapid exclusion of hematological disease by flow cytometric routine panelsMaria Laura Bisegna, Iole Cordone, Nadia Peragine, et al.
British Journal of Haematology|August 16, 2005
The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experienceMassimo Gentile, Francesca Romana Mauro, Elisabetta Calabrese, et al.
Pageof 7